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Abstract
Background Sex differences in acute coronary syn-
drome (ACS) have been reported, but little is known
about the situation in the Netherlands.
Methods This registry is a merge of available data
on ACS patients in the electronic data capture sys-
tems of 11 centres with 24/7 interventional cardiology
services. We included patients >18 years undergoing
a cardiac catheterisation between 2010–2012. We eval-
uated sex differences in clinical and procedural char-
acteristics and 1-year mortality.
Results A total of 29,265 ACS patients (8,720 women
and 20,545 men) were registered. Women were on
average 4.5 years older (68.5 vs 63.0 years, p< 0.001)
and had a higher prevalence of hypertension (62.7 vs
49.8%, p< 0.001) and insulin-dependent diabetes mel-
litus (9.6 vs 6.8%, p< 0.001) than men. Women less
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often presented with ST-elevation myocardial in-
farction (43.7% vs 47.6%, p<0.001) and appeared to
have less extensive coronary artery disease than men.
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by radial access (52.5 vs 55.9%, p< 0.001). One-year
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(p-interaction <0.001).
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What’s new?
 To the best of our knowledge, this is the first time
that data of a sizeable cohort of Dutch ACS pa-
tients are presented on sex differences.
 We merged and analysed data of almost 30,000
ACS patients who were treated in a represen-
tative selection of PCI-capable centres in the
Netherlands.
 We found differences in clinical and procedu-
ral characteristics and outcome between women
andmen admitted for ACS, which are in line with
other Western countries.
 The relation between sex andmortality appeared
age-dependent, with higher mortality in women
at a younger age, in particular in those present-
ing with STEMI, and lower mortality at advanced
age—the turning point was 71 years.
and men admitted for ACS, which are in line with
other Western countries. The limitations of our reg-
istry, based on existing local databases, can be over-
come by the use of the prospective Netherlands Heart
Registry that is currently in development.
Keywords Sex differences · Acute coronary syndrome ·
Registry
Introduction
In the Netherlands, cardiovascular disease (CVD) was
responsible for 25.9% and 24.9% of deaths in women
and men, respectively, in 2017 [1]. Myocardial infarc-
tion (MI), the most common entity of the acute coro-
nary syndrome (ACS), represents 11.0% and 15.6% of
cardiovascular deaths in women and men respectively
[1]. An increasing amount of patients with ACS are
women, due to the ageing of the population, chang-
ing risk profiles and shifts within diagnostic capa-
bilities [2]. Several observational studies found that
women presenting with ACS have a different clinical
presentation than men and are managed differently
[3, 4]. Conflicting results have been revealed about
outcome differences between women and men [5].
Poorer in-hospital clinical outcome has been observed
in women following ST-elevation myocardial infarc-
tion (STEMI), especially at younger age, although less
severe disease has been observed with coronary an-
giography [6].
It is still unclear if these differences can solely be ex-
plained by sex or that they are related to differences in
age, extent or impact of CVD risk factors, presentation
or treatment. Also, whether the above-mentioned ob-
servations can be extrapolated to the situation in the
Netherlands remains uncertain. We aimed to fill this
knowledge gap, with particular focus on ACS patients.
Although a national data registry for ACS patients is
currently in preparation, for now a database contain-
ing representative, nationwide data is still lacking. So
far, only one study reports sex differences on a multi-
centre experience in the Netherlands, based on small
patient numbers [7]. We realised, however, that a wide
variety of information on sizeable sets of ACS patients
is available in the electronic patient record systems of
each (interventional) hospital in the Netherlands. We
merged these data(sets), which created a large (virtual
and retrospective) registry that was then available for
analyses of sex differences.
Methods
Patients and material
This is an observational, retrospective study of ACS
patients treated in the Netherlands. We included pa-
tients aged 18 years and older undergoing cardiac
catheterisation for ACS in the period 2010–2012. We
used data from existing electronic databases in each
of the individual interventional cardiac centres. At the
time we started our study, 30 interventional cardiac
centres existed in the Netherlands. The 24 centres
with electronically available clinical data and an es-
tablished interventional cardiology programme that
offered full 24/7 service were asked to participate.
For several reasons, 13 eligible centres were unable
or unwilling to participate, and thus we present data
from a total of 11 centres.
Fig. 1 Geographical distribution of participating interven-
tional centres. Geographical distribution of participating inter-
ventional centres. Green dots represent participating centres,
red dots represent non-participating centres
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Data were extracted in each individual centre
using a pre-specified list of variables, which was
mainly based on quality of care indicators [8, 9].
Electronically abstracted data included patient de-
mographics, cardiovascular risk factors and history
and characteristics of cardiac procedures. In patients
who underwent multiple procedures within the study
period, only the clinical information of the first pro-
cedure was retained. For the purpose of this study,
patients were not contacted, subjected to acts, and
neither was any mode of behaviour imposed, oth-
erwise than as part of their regular treatment. Data
extracted from the medical records were processed
anonymously, not traceable to individual patients.
Therefore, in accordance with Dutch law, written
informed consent was not required.
Definitions
To enable data merging of different centres, broad
definitions were used. We distinguished STEMI, non-
STEMI (NSTEMI) and unstable angina pectoris (UAP)
as ACS subclasses, according to the European Society
Fig. 2 Study patients ac-
cording to sex and age.
Study patients by sex and
age. Upper part shows per-
centage of the total study
sample of ACS patients by
sex, bottom part shows per-
centage of women per age
stratum. ACS acute coro-
nary syndrome
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of Cardiology guidelines [10]. Prevalent risk factors
including hypertension, hypercholesterolaemia, dia-
betes mellitus, including insulin dependence, smok-
ing and family history of cardiovascular disease were
defined as such in the dataset of the concerning
centre. This also applies to prior MI, percutaneous
coronary intervention (PCI), coronary artery bypass
grafting (CABG) and renal failure. Left ventricular
ejection fraction (LVEF) was defined as good (>50%),
moderately impaired (30–50%) and severely impaired
(<30%). Segment involvement was created using the
coronary artery segments mapping on the coronary
angiogram according to the American Heart Associ-
ation classification [11]. Severity of coronary artery
disease (CAD) was expressed in number of segments
and vessels involved with ≥50% stenosis. Multi-ves-
sel obstructive disease was defined as ≥50% stenosis
in left main artery or ≥50% stenosis in ≥2 separate
epicardial coronary artery territories.
Clinical study endpoint
The clinical study endpoint was all-cause mortality,
which we report at 7-day, 30-day and 1-year follow-
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up. Survival status for each patient was obtained from
municipal civil registries.
Statistical analysis
The availability of specific data items varied between
the participating centres. Descriptive statistics were
provided for all available data. Inferential statistics
(including statistical modelling) was limited to vari-
ables that were available for at least 4 participating
centres.
Continuous variables were expressed asmeans with
standard deviations and medians with interquartile
ranges. Categorical variables are presented as num-
bers with percentages. We used Mann-Whitney tests
(continuous variable) and chi-squared tests (categori-
cal) to evaluate differences between women and men.
Estimates of the cumulative incidence of mortality
were obtained by the method of Kaplan-Meier, and
differences between women and men were evaluated
by the log-rank test. The relationship between sex
and 1-year mortality was further analysed using Cox
Table 1 Baseline characteristics of ACS patients included in the registry; Merged data according to sex
Women Men P-value
N= 8,720 (29.8) N= 20,545 (70.2)
Demographics
Agea 68.5 (12.7) 63.0 (12.0) <0.001
BMIb 27.0 (5.0) 27.2 (3.9) 0.15
Presentation
Systolic blood pressurec 132 (30) 126 (26) <0.001
Diastolic blood pressured 74 (17) 75 (16) 0.063
Risk factors
Hypertension 2,909/4,637 (62.7) 5,535/11,107 (49.8) <0.001
Hypercholesterolaemia 1,896/4,128 (45.9) 4,718/10,021 (47.1) 0.21
Diabetes mellitus 1,300/6,363 (20.4) 2,516/15,285 (16.5) <0.001
Diabetes mellitus type
– Insulin-dependent 213/2,218 (9.6) 364/5,335 (6.8) <0.001
Current smoker 981/3,604 (27.2) 3,099/8,598 (36.0) <0.001
Family history of cardiac disease 1,760/4,376 (40.2) 4,501/10,700 (42.1) 0.037
Cardiovascular history
Prior MI 965/5,113 (18.9) 2,924/12,416 (23.6) <0.001
Prior PCI 850/4,603 (18.5) 2,302/10,885 (21.1) <0.001
Prior CABG 376/6,123 (6.1) 1,283/14,790 (8.7) <0.001
LVEF 0.22
>50% 1,270/1,525 (83.3) 2,906/3,513 (82.7)
30–50% 187/1,525 (12.3) 410/3,513 (11.7)
<30% 68/1,525 (4.5) 197/3,513 (5.6)
Non-cardiovascular history
Renal failure 247/3,350 (7.4) 594/8,366 (7.1) 0.61
ACS acute coronary syndrome, BMI body mass index, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting,
LVEF left ventricular ejection fraction. Continuous variables are expressed as mean (standard deviation) values, categorical variables as counts of the total data
available in women and men (percentage). Percentages may not add to 100 due to rounding
aData were available in 7,701 women, 18,372 men
bData were available in 3,612 women, 8,919 men
cData were available in 1,914 women, 4,758 men
dData were available in 1,914 women, 4,758 men
proportional hazards regression models. We applied
univariable and multivariable analyses, with adjust-
ment for age and further adjustment for 1, potential,
confounder, including body mass index (BMI), hy-
pertension, hypercholesterolaemia, diabetes mellitus,
smoking, family history of CVD, prior MI, prior PCI,
prior CABG, LVEF, renal failure, acute MI, STEMI, ac-
cess site, multi-vessel disease, segment involvement,
multi-lesion procedure, multi-vessel procedure and
use of drug-eluting stent. Full adjustment for multiple
(potential) confounders was not possible as structural
missing data precluded multiple imputation. We in-
troduced a sex*age interaction term in the Cox model
to study the relationship of sex, age and 1-year mor-
tality. As results showed a relevant sex*age interaction
the clinical endpoints were also presented in 5 strata
according to age. Sex differences were analysed in the
entire ACS study population and after categorisation
for STEMI and NSTEMI/UAP patients.
SPSS software, version 24, was used to perform all
analyses. Confidence intervals were calculated at the
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95% level. A p-value below 0.05 (two-sided test) was
considered statistically significant.
Results
Patients
A total of 8,720 (29.8%) women and 20,545 (70.2%)
men with ACS followed by coronary angiography were
included. The number of patients included per centre
ranged from 1,184 to 5,592. The participating centres
had a widespread geographical distribution (Fig. 1).
Baseline characteristics
Women and men had a different age distribution
(Fig. 2). Women were on average 4.5 years older
(mean age 68.5 vs 63.0 years, p< 0.001) and had
Table 2 Procedural characteristics of ACS patients included in the registry; Merged data according to sex
Women Men P-value
N= 8,720 (29.8) N= 20,545 (70.2)
Indication
AMI 4,478/6,882 (65.1) 11,063/16,217 (68.2) <0.001
ACS subtype <0.001
STEMI 2,462/5,635 (43.7) 6,123/12,852 (47.6)
NSTEMI 933/5,635 (16.6) 1,995/12,852 (15.5)
Unstable angina 2,240/5,635 (39.8) 4,734/12,852 (36.8)
Access site <0.001
Radial 2,831/5,393 (52.5) 7,180/12,843 (55.9)
Femoral 2,287/5,393 (42.4) 5,041/12,843 (39.3)
Other 275/5,393 (5.1) 622/12,843 (4.8)
Severity CAD <0.001
No CAD 190/5,583 (3.4) 313/13,653 (2.3)
Single-vessel 2,756/5,583 (49.4) 6,406/13,653 (46.9)
Multi-vessela 2,637/5,583 (47.2) 6,934/13,653 (50.8)
Segment involvement
RCA 2,292/5,372 (42.7) 5,419/13,411 (40.4) 0.004
LAD 2,755/5,378 (51.2) 6,629/13,424 (49.4) 0.022
CX 1,384/5,372 (25.8) 4,078/13,426 (30.4) <0.001
Left main 174/5,348 (3.3) 450/13,356 (3.4) 0.69
Graft 35/3,464 (1.0) 191/8,069 (2.4) <0.001
Number of segmentsb 1 (1–2) 1 (1–2) 0.54
Multi-segment procedure 1,323/4,730 (28.0) 3,251/11,393 (28.6) 0.45
Multi-vessel procedure 1,081/5,355 (20.2) 2,799/13,376 (20.9) 0.26
Implanted stent type 0.15
DES 2,297/4,031 (57.0) 5,765/10,144 (56.8)
BMS 1,042/4,031 (25.8) 2,602/10,144 (25.7)
Combination of DES and BMS 425/4,031 (10.5) 1,002/10,144 (9.9)
Other (including BVS) 267/4,031 (6.6) 775/10,144 (7.6)
ACS acute coronary syndrome, AMI acute myocardial infarction, (N)STEMI (non-)ST-elevation myocardial infarction, CAD coronary artery disease, RCA right
coronary artery, LAD left anterior descending artery, CX circumflex, DES drug-eluting stent, BMS bare-metal stent, BVS bioresorbable vascular scaffold.
Continuous variables are expressed as median (interquartile range) values, categorical variables as counts of the total data available in women and men
(percentage). Percentages may not add to 100 due to rounding
aIncluding two-vessel, three-vessel and left main disease
bData was available in 4,401 women, 10,804 men
a higher prevalence of traditional risk factors for CVD,
including hypertension (62.7 vs 49.8%, p< 0.001) and
insulin-dependent diabetes mellitus (9.6 vs 6.8%,
p< 0.001), but a lower prevalence of current smoking
(27.2 vs 36.0%, p< 0.001), family history of CAD (40.2
vs 42.1%, p=0.037) and history of MI, PCI or CABG.
Almost half of the patients had hypercholesterolaemia
and about 5% of the patients had a severely impaired
LVEF (Tab. 1). Renal failure was comparable between
both groups with 7.4 vs 7.1% (p=0.61).
Procedural characteristics
Procedural data are listed in Tab. 2. A total of 65.1%
women and 68.2% men with ACS underwent coro-
nary angiography for acute MI, of which significantly
less women (43.7%) than men (47.6%) were treated for
STEMI. Fewer women than men underwent coronary
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Fig. 3 Kaplan-Meier curves for all-cause mortality according
to sex and age stratum up to 1-year follow-up. Kaplan-Meier
curves for all-cause mortality in ACS patients according to sex
and age stratum up to 1-year follow-up. ACS acute coronary
syndrome
angiography by radial access (52.5 vs 55.9%). Women
had significantly less extensive CAD with relatively
more single-vessel disease compared with men. Most
lesions were located in the left anterior descending
coronary artery (49.9%), followed by the right coro-
nary artery (41.1%) in both sexes. In women, relatively
fewer stents (per treated segment and in total) were
implanted than in men (46.2 vs 49.4%). Drug-eluting
stents were the most commonly implanted stents in
both women and men.
Mortality
Women had a higher cumulative incidence of all-
cause mortality than men (7.3% vs 5.6%, hazard
ratio [HR] 1.31 and 95% confidence interval [CI]
1.18–1.45, p<0.001). After adjustment for age, the
observed mortality difference disappeared. However,
the sex*age*mortality relation appeared more com-
plex, as we found a statistically significant interaction
between age and sex with respect to 1-year mortality
(p< 0.001). At younger age, women had a higher mor-
tality than men, whereas this pattern was reversed
at elderly age (Fig. 3). Based on the logistic regres-
sion model, the age of 71 years appeared to be the
turning point (Fig. 4). After adjustment for age, the
sex*age interaction term and single variables, female
sex was still associated with higher mortality (data
not shown).
STEMI versus NSTEMI/UAP
Sex-related differences in baseline and the majority of
procedural characteristics of STEMI andNSTEMI/UAP
patients were comparable with the entire ACS popu-
lation (Supplementary data—Tables 1–3). Compared
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Fig. 4 Adjusted all-cause 1-year mortality of the sex*age in-
teraction. Adjusted all cause 1-year mortality of the sex and
age interaction. Red line represents women, blue line repre-
sents men with ACS. ACS acute coronary syndrome
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with STEMI patients, the risk profile of NSTEMI pa-
tients was more unfavourable, except for the risk
factor smoking. Women and men with NSTEMI were
respectively 1.2 and 3.0 years older, had a 21.2 and
22.8% higher incidence of hypertension, 24.5 and
26.7% higher incidence of hypercholesterolaemia,
10.1 and 8.5% higher incidence of diabetes mellitus
and 6.0 and 6.7% more renal failure. The prevalence
of current smoking was 16.3% lower for women and
14.5% lower for men with NSTEMI. Both women
and men with NSTEMI more frequently had a prior
cardiovascular history and had on average a worse
LVEF.
In women and men with STEMI, a femoral ap-
proach was relatively more often applied than in
NSTEMI patients. There were no significant sex-re-
lated differences in CAD severity in STEMI patients.
However, in NSTEMI patients, womenmore often had
non-obstructive and single-vessel disease.
In all age categories, STEMI patients had higher
1-year mortality than NSTEMI patients. Women with
STEMI had higher 1-year mortality than men (9.4%
and 6.8%; respectively p< 0.001). The difference was
most striking at young (≤50 years) age (4.8% and 2.3%,
respectively; p= 0.022) and was seen from 30-day fol-
low-up. Women and men with NSTEMI had similar
mortality (5.0% and 4.3%, respectively; p= 0.15).
Discussion
We merged and analysed data of almost 30,000 ACS
patients who had been treated in a representative se-
lection of PCI-capable centres in the Netherlands. To
the best of our knowledge this is the first time that data
of a sizeable cohort of Dutch ACS patients are pre-
sented. Similar to other countries [12], we found rele-
vant sex differences in clinical and procedural charac-
teristics and outcome. Women were older and more
often had prevalent cardiovascular risk factors, includ-
ing hypertension and diabetes mellitus. Women nev-
ertheless had less extensive macrovascular CAD. The
relation between sex and mortality appeared age-de-
pendent, with higher mortality in women at younger
age, in particular in those presenting with STEMI, and
lower mortality at advanced age—the turning point
was 71 years.
The women:man ratio in our study was 1:2.4, which
is largely in agreement with the Swedish Coronary An-
giography and Angioplasty Registry (SCAAR) registry
data on ACS patients (ratio 1:2.7) and the French Reg-
istry of Acute ST-elevation or non-ST-elevation My-
ocardial Infarction (ratio 1:2.8) [12, 13]. In view of
these international studies, and since we included ‘all-
comers’ in participating hospitals that can be con-
sidered representative for all interventional centres
in the Netherlands, we conclude that fewer women
than men present with ACS necessitating angiogra-
phy. Still, we are aware that we only enrolled patients
who reached the cath lab, which might have resulted
in a somewhat underestimated incidence of ACS in
women. Several studies have shown that women are
insufficiently aware of indicative symptoms, and seek
medical care later than men [14, 15], which might be
fatal in the case of ACS. In addition, studies suggested
that (especially younger) women might present with
complaints that are not suggestive for macrovascular
obstruction [16]. Consequently, these women do not
reach the cath lab. Unfortunately, we cannot quan-
tify the magnitude of these effects on the basis of our
study data.
We included consecutive ACS patients, and found
that women were on average 4 years older than men.
They had less extensive CAD, despite having more
comorbid risk factors including hypertension and di-
abetes mellitus, which is largely in accordance with
previous studies [17, 18]. It is known that women ex-
perience the onset of obstructive CAD approximately
6–8 years later than men, and that they are older
when admitted for their first MI [19]. The most widely
accepted explanation for this phenomenon is that
pre-menopausal women are largely protected against
obstructive CAD by circulating oestrogen [20]. The
cardiovascular risk profile of women worsens once
menopause is over, and the prevalence of chronic
CAD then steeply increases with age, as does the
incidence of acute expressions of the disease.
Women (especially those with NSTEMI) had a
higher incidence of non-obstructive CAD [NOCAD]
than men. It was previously reported that MI with
non-obstructive coronary arteries (MINOCA) is more
often seen in women and in patients with NSTEMI.
Recent publications argue that MINOCA should be
interpreted as a working diagnosis in order to find the
true underlying pathophysiologic mechanism [21]. In
women several mechanisms seem to be responsible
for MINOCA, such as differences in plaque compo-
sition, with women having less plaque burden but
more plaque erosion and thin-cap fibroatheromas
[17]. Other mechanisms include coronary artery
dissection, coronary vasospasm (including microvas-
cular), Takotsubo cardiomyopathy and myocarditis.
Dedicated studies with invasive diagnostic measure-
ments are necessary to disentangle this complex
phenomenon [21, 22].
Our mortality data were similar to the large com-
bined UK/Swedish ACS registry by Kunadian et al.
[19]. In view of the worse risk profile and extent
of coronary obstructions, one would expect more
favourable mortality figures in women than in men,
but results showed the opposite. Several explanations
are postulated for the higher mortality rates in women
with ACS, including lower revascularisation rates and
lower guideline adherence. Recently, Alabas et al.
found higher mortality rates in women with STEMI
compared with men, but not in women with NSTEMI
compared with men after correction for treatment
according to the guidelines [23]. Possibly delayed
presentation, lower rate of referral for angiography
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or bleeding complications play a role in the higher
mortality rates in women [5]. Another explanation
might be a higher incidence of MINOCA, which may
limit clinical attention and is associated with adverse
clinical outcome [22]. Unfortunately, our registration
does not contain sufficient information to disentangle
these phenomena in detail.
Interestingly, the excess mortality in women was
particularly striking in younger STEMI patients—in
fact, elderly women had a lower mortality rate than
men. This finding was also observed by various pre-
vious studies [24, 25]. Cardiovascular risk factors,
including overweight and smoking, are increasingly
prevalent among young women and seem to have
a differential impact on endothelial and microvas-
cular dysfunction than in men, and thus on the
development of CAD [26]. Young women tend to
have more plaque erosion while older women have
plaque rupture [27]. Also, young women have a higher
frequency of alternative aetiologies, including spon-
taneous coronary artery dissection and coronary va-
sospasm. Finally, younger women are less likely to
have chest pain and discomfort, and more likely to
have atypical presentations, potentially leading to
under-recognition or delayed presentation of STEMI,
making acute reperfusion less likely [28]. The excess
mortality in older men can possibly be explained by
the longer exposure to obstructive coronary disease
and shorter life expectancy within men.
Data collection
We were able to collect and merge data of ACS pa-
tients of 11 experienced interventional centres with
a widespread geographical distribution, and thus
to construct a large data set that is unique for the
Netherlands. The majority of the remaining 13 cen-
tres were sympathetic, but were not able to provide
data. They had switched to a new electronic patient
record system, collected data in free text fields or
had no ability to extract data from the data system.
Unlike in Sweden, until now Dutch centres have free-
dom of choosing their own electronic patient record
system, which hampers data sharing. Some of the
centres understandably refused participation because
data were not validated or registered for scientific
purposes. It took a disproportionate amount of time
and energy to validate and merge datasets, whereas
missing data was a serious concern. We recognise
that for more detailed analyses—for example analyses
of time trends—uniform, prospective patient cohorts
are necessary. Clinical registries can be very useful for
outcome monitoring and benchmarking with other
European countries in order to improve the quality of
care. In addition, clinical registries have proven their
value in multi-centre observational research, and in
registry-based randomised clinical trials [29, 30]. The
Netherlands Society of Cardiology recognised that we
should no longer lag behind other European coun-
tries, and initiated a national ACS registry. We expect
the first results within 5 years from now.
Limitations
Several limitations of our work warrant discussion.
The retrospective design represents a serious draw-
back, but also highlights a sobering fact: a proper,
prospective, nationwide ACS registry is still lacking in
the Netherlands. We validated data (definitions and
outliers) at hospital level, but validation on patient
level was not feasible. We are aware of the selec-
tion bias that is created by studying only patients ad-
mitted to the cath lab, and thus neglecting conserva-
tively treated patients. Remarkably and inexplicably,
we found more missing data in women than in men.
Due to missing data, we were not able to perform a full
multivariable regression analysis. Also, we could not
report on details of clinical and procedural character-
istics, including angiographic data and time intervals.
Especially time intervals would have been very inter-
esting in view of previous described sex differences
in the literature and the excellent logistics concern-
ing STEMI care in the Netherlands. All in all, given
that 46% of interventional hospitals participated, with
satisfactory geographical distribution, and given the
large sample size, our data provide a reasonable in-
sight in ACS management, and sex differences in ACS
management, in our country. It is reassuring to learn
that our findings were similar to other national reg-
istries, including the United Kingdom and Sweden.
Conclusion
In this retrospective study, based on data from a rep-
resentative selection of PCI-capable centres in the
Netherlands, differences were observed in clinical
and procedural characteristics and in outcome be-
tween women and men presenting with ACS and
admitted for coronary angiography, which are similar
to other Western countries. Female sex was associated
with higher all-cause mortality up to one year after
ACS admission in young patients, especially in those
presenting with STEMI. Data provided from registries
are important to improve the quality of care of the
entire population of ACS patients, but especially in
groups that are underrepresented in clinical trials,
including women. Our study underscores the impor-
tance of a national registry of ACS patients in order
to monitor treatment quality and trends in treatment
quality, patient outcome, as well as for benchmarking
purposes.
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